IDENTIFYING BIOMARKERS OF HUMAN VCA REJECTION TO ENABLE NONINVASIVE DIAGNOSTIC TESTING

$499,998FY2024Defense Health AgencyDOD

Brigham & Womens Hospital Inc

Investigators

View source on USAspending →